T-0156
![]() | |
| Names | |
|---|---|
| IUPAC name
Methyl 2-[(2-methylpyridin-4-yl)methyl]-1-oxo-8-(pyrimidin-2-ylmethoxy)-4-(3,4,5-trimethoxyphenyl)-2,7-naphthyridine-3-carboxylate | |
| Other names
T0156; Tocris-1676 | |
| Identifiers | |
| ChemSpider | 5175 8027754 (HCl) |
| 5275 | |
| Jmol interactive 3D | Image |
| PubChem | 5368 9852041 (HCl) |
| |
| |
| Properties | |
| C31H29N5O7 | |
| Molar mass | 583.60 g·mol−1 |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| Infobox references | |
T-0156 is a phosphodiesterase inhibitor.[1]
References
- ↑ "Role of new agents affecting NO/cGMP pathway on ovalbumin-sensitized guinea pig trachea". Exp. Lung Res. 38 (8): 420–6. October 2012. doi:10.3109/01902148.2012.719281. PMID 23030645.
This article is issued from Wikipedia - version of the Tuesday, July 07, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
